Albert Seymour is CSO at Homology Medicines, Inc. (FIXX). They have made 9 open-market trades across 1 company since 2019, most recently 2023-09-06.
CIK 0001735324
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FIXX | 150,874 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2023-09-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FIXX | SELL · 10b5-1 | 2023-09-06 | 2023-09-08 | $1.15 | $2K | +1.7% | -6.9% | -50.4% |
| FIXX | SELL · 10b5-1 | 2023-01-09 | 2023-01-11 | $1.39 | $5K | +2.5% | -11.6% | -37.2% |
| FIXX | SELL · 10b5-1 | 2022-01-05 | 2022-01-12 | $3.78 | $6K | -6.5% | +1.3% | -40.4% |
| FIXX | SELL | 2021-01-06 | 2021-01-08 | $12.06 | $362K | +2.1% | +18.3% | -40.2% |
| FIXX | SELL | 2021-01-05 | 2021-01-07 | $11.44 | $114K | +5.7% | +16.1% | -43.7% |
| FIXX | SELL | 2020-01-02 | 2020-01-03 | $20.50 | $374K | -6.0% | -9.4% | -12.3% |
| FIXX | SELL | 2019-11-29 | 2019-12-03 | $16.15 | $300K | +13.8% | +12.8% | -6.6% |
| FIXX | SELL | 2019-10-01 | 2019-10-02 | $17.39 | $162K | -18.7% | -25.0% | +22.0% |
| FIXX | SELL | 2019-09-03 | 2019-09-05 | $18.74 | $174K | +7.4% | -22.3% | -10.5% |
| FIXX | SELL | 2019-08-01 | 2019-08-05 | $17.37 | $162K | -1.8% | +20.3% | -21.4% |
| FIXX | SELL | 2019-07-01 | 2019-07-03 | $18.99 | $177K | +10.1% | -11.9% | -8.0% |
| FIXX | SELL | 2019-06-03 | 2019-06-05 | $19.90 | $185K | -3.3% | -7.9% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.